Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPChFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia, feline chlamydiosis (live) and feline leukemia (RNA replicon particle) vaccine, Status: Opinion

Veterinary medicines European public assessment report (EPAR): Nobivac NXT FeLV, feline leukemia (RNA particle) vaccine, Status: Opinion

EMA workshop on the challenges in drug development, regulation and clinical practice in immune thrombocytopenia, Online, from 30 June 2026, 14:00 (CEST) to 30 June 2026, 18:00 (CEST)

EMA/PE/0000233797

EMA/PE/0000189672

Opinion/decision on a Paediatric investigation plan (PIP): Lupkynis, voclosporin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0152/2019

EMA/PE/0000228536

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0298/2024

Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Date of authorisation: 23/03/2018, Revision: 12, Status: Authorised